The Role of Cardiovascular MRI in Cardio-Oncology.
The Role of Cardiovascular MRI in Cardio-Oncology.
复制标题
DOI：
10.1016/j.hfc.2020.08.009
复制
发表时间：
2021-01
影响因子：
3.4
通讯作者：
Hundley WG
中科院分区：
文献类型：
--
作者：
Bottinor W;Trankle CR;Hundley WG
随着心血管疾病成为接受癌症治疗的个体和癌症幸存者中发病率和死亡率的主要原因，心血管磁共振（CMR）越来越多地用于识别那些有心脏或血管损伤风险或患有心脏或血管损伤的患者。1，2在心脏肿瘤学领域，CMR的作用尚未完全确定，但CMR建议用于超声心动图窗口差、LVEF临界值或临床值不一致的个体。3-5此外，CMR在检测亚临床心血管疾病方面可能特别有用。我们讨论了CMR在各种临床情况下的价值，包括促进临床和亚临床疾病的左心室和右心室收缩功能障碍、肌细胞萎缩、免疫检查点抑制剂（ICI）介导的心肌炎、心脏淀粉样变性、心肌纤维化、血容量减少和早期肌细胞损伤的识别（表1）。我们描述了在这些临床场景中可能有用的CMR技术（图1）。最后，我们评估了当前和未来利用CMR的研究工作，以进一步了解癌症或其治疗导致的心血管疾病。
With cardiovascular disease emerging as a leading cause of morbidity and mortality among individuals undergoing treatment for cancer and cancer survivors, cardiovascular magnetic resonance (CMR) is increasingly utilized to identify those at risk for or with evolving cardiac or vascular injury. 1, 2 Within the field of cardio-oncology, the role of CMR has not been fully defined, however CMR is suggested for individuals with poor echocardiographic windows, a borderline LVEF, or discrepant clinical values. 3–5 Additionally, CMR may be particularly useful in detecting subclinical cardiovascular disease.Here we review current data guiding the role of CMR in cardio-oncology. We discuss the value of CMR in a variety of clinical scenarios including left and right ventricular systolic dysfunction that promotes both clinical and subclinical disease, myocyte atrophy, immune check point inhibitor (ICI) mediated myocarditis, cardiac amyloidosis, myocardial fibrosis, hypovolemia, and the identification of early myocellular injury (Table 1). We describe CMR techniques that can be useful in these clinical scenarios (Fig. 1). Lastly, we evaluate current and future investigative efforts utilizing CMR to further our understanding of cardiovascular disease as a result of cancer or its treatment.
登录
查看更多内容
DOI：
10.1016/j.jcmg.2018.05.012
发表时间：
2018-08
期刊：
JACC. Cardiovascular imaging
影响因子：
--
作者：
Ferreira de Souza T;Quinaglia A C Silva T;Osorio Costa F;Shah R;Neilan TG;Velloso L;Nadruz W;Brenelli F;Sposito AC;Matos-Souza JR;Cendes F;Coelho OR;Jerosch-Herold M;Coelho-Filho OR
通讯作者：
Coelho-Filho OR
DOI：
10.1161/circimaging.115.004325
发表时间：
2016-08
期刊：
Circulation. Cardiovascular imaging
影响因子：
--
作者：
Jordan JH;Vasu S;Morgan TM;D'Agostino RB Jr;Meléndez GC;Hamilton CA;Arai AE;Liu S;Liu CY;Lima JA;Bluemke DA;Burke GL;Hundley WG
通讯作者：
Hundley WG
影响因子：
39.3
作者：
Lopez-Sendon, Jose;Alvarez-Ortega, Carlos;Lopez Fernandez, Teresa
通讯作者：
Lopez Fernandez, Teresa
影响因子：
39.3
作者：
Bellenger, NG;Burgess, MI;Pennell, DJ
通讯作者：
Pennell, DJ
DOI：
10.1161/circimaging.115.003584
发表时间：
2016-12
期刊：
Circulation. Cardiovascular imaging
影响因子：
--
作者：
Farhad H;Staziaki PV;Addison D;Coelho-Filho OR;Shah RV;Mitchell RN;Szilveszter B;Abbasi SA;Kwong RY;Scherrer-Crosbie M;Hoffmann U;Jerosch-Herold M;Neilan TG
通讯作者：
Neilan TG